[Psychopharmacological therapy in mental retardation--comparison of the years 1991 and 2005]
- PMID: 20703984
- DOI: 10.1055/s-0030-1248500
[Psychopharmacological therapy in mental retardation--comparison of the years 1991 and 2005]
Abstract
Objective: About psychopharmacological long-term care in individuals with mental retardation there are only a few data. The objective of this investigation was to analyze psychopharmacotherapy over a period of 15 years.
Methods: For the year 1991 291 data sets and for the year 2005 288 data sets of all residents of a home for people with mental retardation were analysed.
Results: The number of psychiatric disorders has not changed. But the frequency of medication with neuroleptics and antidepressive compounds has increased. Atypical and typical neuroleptics did not differ significantly in side effects. But the number of side effects in SSRI's is compared with tricyclic antidepressive compounds significantly reduced.
Conclusions: The present study is one of the few, which gives an overview of long-term course of psychiatric disorders in people with mental retardation, the psychopharmacological therapy und side effects of used medication.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Novel psychotropic medications in children: new toxicities to master.Pediatr Emerg Care. 2001 Jun;17(3):226-31. doi: 10.1097/00006565-200106000-00020. Pediatr Emerg Care. 2001. PMID: 11437154 Review. No abstract available.
-
[Psychopharmacological treatment of patients in a university department of internal medicine].Dtsch Med Wochenschr. 2014 Feb;139(9):417-22. doi: 10.1055/s-0034-1369817. Epub 2014 Feb 20. Dtsch Med Wochenschr. 2014. PMID: 24557994 German.
-
Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.J Autism Dev Disord. 1997 Feb;27(1):89-102. doi: 10.1023/a:1025825322955. J Autism Dev Disord. 1997. PMID: 9018584 No abstract available.
-
Are psychotropic drugs at therapeutic levels a concern for cardiologists?Can J Cardiol. 1997 Jan;13(1):75-80. Can J Cardiol. 1997. PMID: 9039069 Review.
-
Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.Res Dev Disabil. 2010 Jan-Feb;31(1):108-16. doi: 10.1016/j.ridd.2009.08.002. Epub 2009 Aug 31. Res Dev Disabil. 2010. PMID: 19720497
Cited by
-
Polypharmacy in the treatment of subjects with intellectual disability.J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S93-100. doi: 10.1007/s00702-014-1219-x. Epub 2014 May 25. J Neural Transm (Vienna). 2015. PMID: 24858727 Review.
-
[Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].Nervenarzt. 2017 Nov;88(11):1273-1280. doi: 10.1007/s00115-016-0211-0. Nervenarzt. 2017. PMID: 27638741 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources